Growth Trial: Study of the Renata Minima Stent

Key facts

Sponsor

Renata Medical

Principal Investigator

Darren Berman, MD

Children's Hospital Los Angeles

Intervention

Catheterized Stenting(device)

Enrollment

42 enrolled

Eligibility

All sexes

Timeline

2021 – 2028

Study locations (7)

• Children's Hospital Los Angeles, Los Angeles, California, United States
• Cedars-Sinai Medical Center, Los Angeles, California, United States
• Boston Children's, Boston, Massachusetts, United States
• Cincinnati Children's Hospital, Cincinnati, Ohio, United States
• Nationwide Children's, Columbus, Ohio, United States
• Le Bonheur Children's, Memphis, Tennessee, United States
• Seattle Children's Hospital, Seattle, Washington, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for OBSOLETE: Autosomal dominant coarctation of aorta

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONNCT07134621
  Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension
  University Medical Centre Ljubljana
• RECRUITINGNANCT07316855
  Evaluating the Feasibility of Bioresorbable Iron-Based Covered Stent: A Clinical Trial
  Shubo Song
• ENROLLING BY INVITATIONNCT05880576
  The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
  Boston Children's Hospital
• RECRUITINGNCT06759103
  Electronic Archive of Patients With Diagnosis and Suspected Prenatal Diagnosis of Aortic Coarctation
  IRCCS Azienda Ospedaliero-Universitaria di Bologna
• ACTIVE NOT RECRUITINGNCT05362721
  PV Loop & Coarctation Study
  University of Minnesota

See all trials for OBSOLETE: Autosomal dominant coarctation of aorta →